保留生育功能治疗的子宫内膜癌及不典型增生患者生活质量及影响因素
本研究纳入134例接受保留生育功能治疗的早期子宫内膜癌及不典型子宫内膜增生患者,采用FACT-G量表每3个月评估生活质量。多因素分析显示完全缓解时FACT-G评分与基线评分正相关、与BMI负相关,治疗方式与生活质量无关。长期治疗组生活质量相对较低。
要点
- BMI较高与保留生育功能治疗患者完全缓解时生活质量较低独立相关。
- 治疗方式(GnRHa联合芳香化酶抑制剂对比大剂量口服孕激素)与生活质量无显著相关性。
- 治疗周期≥9个月者FACT-G中位评分持续低于80分,需关注长期治疗对生活质量的影响。
核心结论
- 在保留生育功能治疗中,BMI可能是影响患者生活质量的关键因素。
- 长期治疗可能导致生活质量下降,临床应重视体重管理与心理社会支持。
研究设计与样本
- 单中心纳入2023年8月至2024年12月北京协和医院接受保育治疗的EC及AEH患者134例。
- 按治疗持续时间分为3个月组(n=79)、6个月组(n=40)及≥9个月组(n=15)。
- 采用FACT-G第4版每3个月评估生活质量,多因素线性回归分析影响因素。
主要发现
- 134例中AEH 61例(45.5%)、EC 73例(54.5%);GnRHa联合芳香化酶抑制剂71例(53.0%),大剂量口服孕激素63例(47.0%)。
- 3个月组和6个月组FACT-G评分较基线逐渐升高,≥9个月组治疗过程中中位FACT-G评分均在80分以下。
- 三组CR时FACT-G评分差异无统计学意义(中位82.0、83.0、76.5分;H=1.575,P=0.455)。
- 多因素分析示CR时FACT-G评分与基线FACT-G评分正相关(B=0.634,P<0.001),与BMI负相关(B=-4.021,P=0.035)。
临床怎么用
- 保育治疗期间应关注患者体重管理,BMI较高者可能需加强生活质量监测。
- 对治疗周期较长(≥9个月)的患者应重视心理社会支持。
- 治疗方式选择时生活质量不作为主要区分因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the quality of life (QoL) and its influencing factors in patients with early-stage endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) undergoing fertility-sparing treatment. Methods: A total of 134 patients with EC or AEH who received fertility-sparing treatment at Peking Union Medical College Hospital between August 2023 and December 2024 were enrolled. Patients were divided into two treatment groups: those receiving gonadotropin-releasing hormone agonist (GnRHa) combined with aromatase inhibitors, and those receiving high-dose oral progestins. During treatment, diagnostic curettage or hysteroscopy was performed every 3 months, and treatment was discontinued upon assessment of complete response (CR). According to treatment duration (time to achieve CR), patients were categorized into the 3-month group (n=79), 6-month group (n=40), and ≥9-month group (n=15). The Functional Assessment of Cancer Therapy-General (FACT-G) version 4 was used to quantitatively assess QoL during treatment; questionnaires were administered every 3 months, and all 134 patients completed the survey at baseline and at 3, 6, and 9 months of treatment. Multivariate linear regression analysis was used to analyzed the influencing factors of QoL. Results: Among the 134 patients, 61 (45.5%) had AEH and 73 (54.5%) had EC; 71 patients (53.0%) received GnRHa combined with aromatase inhibitors, and 63 (47.0%) received high-dose oral progestins. QoL assessment showed that FACT-G scores gradually increased from baseline in the 3-month and 6-month groups, indicating improvement in QoL as treatment progressed; whereas the median FACT-G scores in the ≥9-month group remained below 80 throughout treatment, indicating relatively lower QoL. However, there was no statistically significant difference in FACT-G scores at CR among the 3-month, 6-month, and ≥9-month groups (median scores: 82.0, 83.0, and 76.5, respectively; H=1.575, P=0.455). Univariate analysis showed no significant differences in FACT-G scores at CR among patients with different treatment regimens, body mass index (BMI), treatment duration, pathological type, marital status, treatment history, or reproductive history (all P>0.05). Multivariate analysis showed that FACT-G scores at CR were positively correlated with baseline FACT-G scores (B=0.634, P<0.001) and negatively correlated with BMI (B=-4.021, P=0.035). No correlation was observed between treatment regimen and QoL. Conclusions: In fertility-sparing treatment, BMI may be a key factor affecting QoL, while long-term treatment may lead to a decline in QoL. Clinical attention should be paid to weight management and psychosocial support. 目的: 探讨接受保留生育功能治疗的早期子宫内膜癌(EC)及不典型子宫内膜增生(AEH)患者的生活质量及其影响因素。 方法: 纳入2023年8月至2024年12月于北京协和医院接受保育治疗的EC及AEH患者134例。患者治疗方式分为促性腺激素释放激素激动剂(GnRHa)联合芳香化酶抑制剂、大剂量口服孕激素2种,治疗期间每3个月进行诊断性刮宫或宫腔镜检查,评估为完全缓解(CR)的停止治疗。按治疗持续时间(获得CR的时间)将患者分为3个月组(n=79)、6个月组(n=40)及≥9个月组(n=15)。采用肿瘤治疗功能评估系统通用模块(FACT-G)第4版对患者治疗过程中的生活质量状况进行量化评估,每3个月对患者开展1次问卷调查,134例患者均在治疗前及治疗3个月时、6个月时、9个月时参与调查。采用多因素线性回归模型分析患者生活质量的影响因素。 结果: 134例患者中,AEH 61例(45.5%),EC 73例(54.5%);71例(53.0%)接受GnRHa联合芳香化酶抑制剂治疗,63例(47.0%)接受大剂量口服孕激素治疗。生活质量评估结果显示,3个月组和6个月组FACT-G评分较基线逐渐升高,提示生活质量随治疗推进有所改善;而≥9个月组在治疗过程中的中位FACT-G评分均在80分以下,相对更低。但3个月组、6个月组、≥9个月组患者CR时的FACT-G评分差异无统计学意义(中位FACT-G评分分别为82.0、83.0、76.5分;H=1.575,P=0.455)。单因素分析结果显示,不同治疗方式、体质指数(BMI)、治疗时间、病理类型、婚姻状况、治疗史及孕产史的患者,CR时FACT-G评分未见显著差异(均P>0.05)。多因素分析结果显示,患者CR时FACT-G评分与基线FACT-G评分呈正相关(B=0.634,P<0.001),与BMI呈负相关(B=-4.021,P=0.035)。未观察到不同治疗方式与患者生活质量的相关性。 结论: 在保育治疗中,BMI可能是影响患者生活质量的关键因素,但长期治疗可能导致生活质量下降,临床应重视体重管理与心理社会支持。.
引用
- Cao Y, Liu Q, Zhou HM, et al. [Quality of life assessment and influencing factors in patients with endometrial cancer and atypical endometrial hyperplasia undergoing fertility-sparing treatment]. Zhonghua Zhong Liu Za Zhi. 2026. PMID: 42477926. doi:10.3760/cma.j.cn112152-20250831-00431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。